Jane Street
CYT

Jane Street’s Cyteir Therapeutics, Inc. Common Stock CYT Stock Holding History

Jane Street’s Portfolio CYT Stock Details CYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-41,602
Closed -$126K – 10361
2023
Q4 		$126K Buy
+41,602
New +$126K ﹤0.01% 8476
2022
Q1 		– Sell
-15,843
Closed -$180K – 11242
2021
Q4 		$180K Buy
+15,843
New +$241K ﹤0.01% 8891

Other funds holding CYT

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFO
Boston Family Office Boston, Massachusetts $1.5B AUM 11.68% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return

Jane Street's CYT Position: Q1 2024 in Review

Jane Street sold out of Cyteir Therapeutics, Inc. Common Stock (CYT) in Q1 2024, closing a stake of 41,602 shares — an estimated $126K sold.

Jane Street first reported a position in CYT in Q4 2021 and held it in 2 quarters. The position peaked at $180K in Q4 2021. 4 funds tracked by Wall St. Rank hold CYT as of Q1 2024.

  • Jane Street reported no remaining Cyteir Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Jane Street sold 41,602 Cyteir Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $126K.
  • Jane Street first reported a position in Cyteir Therapeutics, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
  • Jane Street's Cyteir Therapeutics, Inc. Common Stock position peaked at $180K in Q4 2021.
  • 4 funds tracked by Wall St. Rank held Cyteir Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Jane Street's 13F filing for Q1 2024, filed 16 May 2024.